Cargando…

Origin of myofibroblasts in liver fibrosis

Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, David A, Kisseleva, Tatiana, Scholten, David, Paik, Yong Han, Iwaisako, Keiko, Inokuchi, Sayaka, Schnabl, Bernd, Seki, Ekihiro, De Minicis, Samuele, Oesterreicher, Christoph, Taura, Kojiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368775/
https://www.ncbi.nlm.nih.gov/pubmed/23259769
http://dx.doi.org/10.1186/1755-1536-5-S1-S17
_version_ 1782234988044877824
author Brenner, David A
Kisseleva, Tatiana
Scholten, David
Paik, Yong Han
Iwaisako, Keiko
Inokuchi, Sayaka
Schnabl, Bernd
Seki, Ekihiro
De Minicis, Samuele
Oesterreicher, Christoph
Taura, Kojiro
author_facet Brenner, David A
Kisseleva, Tatiana
Scholten, David
Paik, Yong Han
Iwaisako, Keiko
Inokuchi, Sayaka
Schnabl, Bernd
Seki, Ekihiro
De Minicis, Samuele
Oesterreicher, Christoph
Taura, Kojiro
author_sort Brenner, David A
collection PubMed
description Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibroblasts appear early in experimental and clinical liver injury. The origin of the myofibroblast in liver fibrosis is still unresolved. The possibilities include activation of endogenous mesenchymal cells including fibroblasts and hepatic stellate cells, recruitment from the bone marrow, and transformation of epithelial or endothelial cells to myofibroblasts. In fact, the origin of myofibroblasts may be different for different types of chronic liver diseases, such as cholestatic liver disease or hepatotoxic liver disease. This review will examine our current understanding of the liver myofibroblast.
format Online
Article
Text
id pubmed-3368775
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33687752012-06-07 Origin of myofibroblasts in liver fibrosis Brenner, David A Kisseleva, Tatiana Scholten, David Paik, Yong Han Iwaisako, Keiko Inokuchi, Sayaka Schnabl, Bernd Seki, Ekihiro De Minicis, Samuele Oesterreicher, Christoph Taura, Kojiro Fibrogenesis Tissue Repair Proceedings Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibroblasts appear early in experimental and clinical liver injury. The origin of the myofibroblast in liver fibrosis is still unresolved. The possibilities include activation of endogenous mesenchymal cells including fibroblasts and hepatic stellate cells, recruitment from the bone marrow, and transformation of epithelial or endothelial cells to myofibroblasts. In fact, the origin of myofibroblasts may be different for different types of chronic liver diseases, such as cholestatic liver disease or hepatotoxic liver disease. This review will examine our current understanding of the liver myofibroblast. BioMed Central 2012-06-06 /pmc/articles/PMC3368775/ /pubmed/23259769 http://dx.doi.org/10.1186/1755-1536-5-S1-S17 Text en Copyright ©2012 Brenner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Brenner, David A
Kisseleva, Tatiana
Scholten, David
Paik, Yong Han
Iwaisako, Keiko
Inokuchi, Sayaka
Schnabl, Bernd
Seki, Ekihiro
De Minicis, Samuele
Oesterreicher, Christoph
Taura, Kojiro
Origin of myofibroblasts in liver fibrosis
title Origin of myofibroblasts in liver fibrosis
title_full Origin of myofibroblasts in liver fibrosis
title_fullStr Origin of myofibroblasts in liver fibrosis
title_full_unstemmed Origin of myofibroblasts in liver fibrosis
title_short Origin of myofibroblasts in liver fibrosis
title_sort origin of myofibroblasts in liver fibrosis
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368775/
https://www.ncbi.nlm.nih.gov/pubmed/23259769
http://dx.doi.org/10.1186/1755-1536-5-S1-S17
work_keys_str_mv AT brennerdavida originofmyofibroblastsinliverfibrosis
AT kisselevatatiana originofmyofibroblastsinliverfibrosis
AT scholtendavid originofmyofibroblastsinliverfibrosis
AT paikyonghan originofmyofibroblastsinliverfibrosis
AT iwaisakokeiko originofmyofibroblastsinliverfibrosis
AT inokuchisayaka originofmyofibroblastsinliverfibrosis
AT schnablbernd originofmyofibroblastsinliverfibrosis
AT sekiekihiro originofmyofibroblastsinliverfibrosis
AT deminicissamuele originofmyofibroblastsinliverfibrosis
AT oesterreicherchristoph originofmyofibroblastsinliverfibrosis
AT taurakojiro originofmyofibroblastsinliverfibrosis